|
1
|
Njei B, Rotman Y, Ditah I and Lim JK:
Emerging trends in hepatocellular carcinoma incidence and
mortality. Hepatology. 61:191–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yin G, Liu Z, Wang Y, Dou C, Li C, Yang W,
Yao Y, Liu Q and Tu K: BCORL1 is an independent prognostic marker
and contributes to cell migration and invasion in human
hepatocellular carcinoma. BMC Cancer. 16:1032016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anwar SL and Lehmann U: MicroRNAs:
Emerging novel clinical biomarkers for hepatocellular carcinomas. J
Clin Med. 4:1631–1650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Belzen N, Diesveld MP, van der Made
AC, Nozawa Y, Dinjens WN, Vlietstra R, Trapman J and Bosman FT:
Identification of mRNAs that show modulated expression during colon
carcinoma cell differentiation. Eur J Biochem. 234:843–848. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Belzen N, Dinjens WN, Eussen BH and
Bosman FT: Expression of differentiation-related genes in
colorectal cancer: Possible implications for prognosis. Histol
Histopathol. 13:1233–1242. 1998.PubMed/NCBI
|
|
6
|
Huang P, Cao K and Zhao H: Screening of
critical genes in lung adenocarcinoma via network analysis of gene
expression profile. Pathol Oncol Res. 20:853–858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Z, Xu D, Gao Y, Liu Y, Ren J, Yao Y,
Yin L, Chen J, Gan S and Cui X: Immature colon carcinoma transcript
1 is essential for prostate cancer cell viability and
proliferation. Cancer Biother Radiopharm. 30:278–284. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lao X, Feng Q, He G, Ji M, Zhu D, Xu P,
Tang W, Xu J and Qin X: Immature colon carcinoma transcript-1
(ICT1) expression correlates with unfavorable prognosis and
survival in patients with colorectal cancer. Ann Surg Oncol.
23:3924–3933. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, He J, Zhang S, Yang Q, Wang B, Liu
Z and Wu X: Knockdown of immature colon carcinoma transcript 1
inhibits proliferation and promotes apoptosis of non-small cell
lung cancer cells. Technol Cancer Res Treat. 16:559–569. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang C, Liang C, Feng W, Xia X, Chen F,
Qiao E, Zhang X, Chen D, Ling Z and Yang H: ICT1 knockdown inhibits
breast cancer cell growth via induction of cell cycle arrest and
apoptosis. Int J Mol Med. 39:1037–1045. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj
P, Cheow PC, Chow PK, Ooi LL and Chung AY: Importance of tumor size
as a prognostic factor after partial liver resection for solitary
hepatocellular carcinoma: Implications on the current AJCC staging
system. J Surg Oncol. 113:89–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu L, Zhou L, Cheng Y, Sun L, Fan J, Liang
J, Guo M, Liu N and Zhu L: MicroRNA-543 acts as an oncogene by
targeting PAQR3 in hepatocellular carcinoma. Am J Cancer Res.
4:897–906. 2014.PubMed/NCBI
|
|
16
|
Huang Z, Zhou X, He Y, Ke X, Wen Y, Zou F
and Chen X: Hyperthermia enhances 17-DMAG efficacy in
hepatocellular carcinoma cells with aggravated DNA damage and
impaired G2/M transition. Sci Rep. 6:380722016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng P, Li Y, Yang L, Wen Y, Shi W, Mao
Y, Chen P, Lv H, Tang Q and Wei Y: Hepatitis B virus X protein
(HBx) induces G2/M arrest and apoptosis through sustained
activation of cyclin B1-CDK1 kinase. Oncol Rep. 22:1101–1107.
2009.PubMed/NCBI
|
|
18
|
Gai X, Tu K, Li C, Lu Z, Roberts LR and
Zheng X: Histone acetyltransferase PCAF accelerates apoptosis by
repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma. Cell
Death Dis. 6:e17122015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ou X, Lu Y, Liao L, Li D, Liu L, Liu H and
Xu H: Nitidine chloride induces apoptosis in human hepatocellular
carcinoma cells through a pathway involving p53, p21, Bax and
Bcl-2. Oncol Rep. 33:1264–1274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q,
Ning BF, Zhang PP, Zhou WP, Xie WF, Chen WS, et al: Hepatocyte
nuclear factor-4α reverses malignancy of hepatocellular carcinoma
through regulating miR-134 in the DLK1-DIO3 region. Hepatology.
58:1964–1976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zha R, Guo W, Zhang Z, Qiu Z, Wang Q, Ding
J, Huang S, Chen T, Gu J, Yao M, et al: Genome-wide screening
identified that miR-134 acts as a metastasis suppressor by
targeting integrin β1 in hepatocellular carcinoma. PLoS One.
9:e876652014. View Article : Google Scholar : PubMed/NCBI
|
